Biotech Stocks Can Provide Growth and Value in a Volatile Market
Biotech Stocks Can Provide Growth and Value With rising rates traders and portfolio managers are rebalancing to value. Healthcare stocks lagged in February with the rebalancing. Small caps of all shapes and sizes still looks good. Speculation is active. We alerted you on a Feb 15 post that a...
Whoa -Do We have Stealth Correction in Biotech Stocks?…Update-2
Update-2 2/25...Correction seems more real just after market indices hit new highs yesterday: QQQ down 3.49% piercing 200 MA at $312.83. An unusual down day when both bonds and stocks take a hit over concerns about rapidly rising 10 yr TSY rates now yielding 1.518%. The TLT has been in a...
Large Cap Biopharma Stalled With Move to Small Caps and Reflation Trade…Update-2 Sell-Off
Update-2 2/17-11a...Biopharma stocks up on a down day: ABBV, AZN, BMY, MRK, VRTX with IBB off 0.5%. Update-1 Continued Sell-off in Biopharma and now Coronavirus Stocks The market was flattish with slight gains for the DOW, Financials were strong with TSY yields at one year high. Energy was...
Healthcare Sector Lags But Small Caps are Strong…Update-1 -FEB 11-AXDX, GNMK
Update-1 FEB 11, Momentum easing with some good stocks moves, XBI off 1.3% to $165.83. Coronavirus focus stocks are mixed with our holdings doing well. ABT up 1.24%, HOLX up 0.53% and Genmark Diagnostics (GNMK) up 33% to $22.46 on rumors of being acquired, but nothing confirmed. Orasure (OSUR)...
Healthcare Portfolio Update -January 2021…Update-1 Strong bounce-back
Update-1 Strong bounce-back with NAZ up 2.55% and XBI up 4.36% to $159.54 XBI rally mirrors IWM up 2.62%. Technology running strong with QQQ up 2.72%. Second their COVID Vaccine plays up again:INO, NVAX: MRNA downgrade by BofA. Bipartisan stim talks ongoing. ====== Healthcare Portfolio Update...
